Addus (ADUS) Q1 2025 Earnings Call Transcript

Addus HomeCare posted a strong Q1 with revenue up 20.3% to $337.7 million, adjusted EPS up 17.4% to $1.42, and adjusted EBITDA up 25.1% to $40.6 million, aided by the first full quarter of Gentiva Personal Care. Personal Care same-store revenue grew 7.4% and hospice same-store revenue grew 9.9%, while management said margin seasonality remains supportive and full-year adjusted EBITDA margin should stay above 12%. The company also highlighted a $280 million annualized revenue contribution from Gentiva, $97 million in cash, and continued acquisition opportunities, while noting limited direct exposure to potential ACA Medicaid rollbacks.

Analysis

ADUS is inflecting from a pure acquisition story into a self-funding compounding model. The subtle positive is that the Gentiva deal is not just adding revenue; it is expanding Texas density and creating a larger referral/route network that should raise scheduling efficiency, improve service percentages, and lower unit labor leakage over time. That matters because in this business, small operational gains compound disproportionately once you cross local scale thresholds, especially when reimbursement is sticky and the cost base is largely wage-driven.

The market may be underestimating how much of the earnings durability is now coming from mix and operating leverage rather than just rate hikes. Personal care hiring and fill rates are the real leading indicators: if management can sustain 2%+ hours growth while keeping turnover in the low-50s, the company can continue to translate modest census gains into outsized EBITDA expansion. The Gentiva integration also appears to be reducing execution risk rather than increasing it, which should compress the discount investors assign to Addus’ acquisition-heavy growth model.

The main near-term risk is not demand; it is reimbursement timing and state budget noise. Illinois DSO remains the cleanest watch item because cash conversion can mask underlying operating strength or weakness for a quarter or two, and Texas is the biggest open catalyst for incremental rate support over the next 30-60 days. If Texas comes through and Illinois remains stable, the setup becomes one where Q2/Q4 margin seasonality plus M&A optionality can re-rate the stock higher; if not, the shares could stall despite good top-line growth because investors will question how much of the current margin is truly recurring.

Contrarian view: the consensus is probably too focused on headline growth and not enough on the fact that Addus is building a more defensible local-services moat. The real second-order bull case is that the caregiver app and scheduling tooling, if replicated across states, could permanently lift utilization and reduce dependence on brute-force hiring. That is a longer-dated story, but it creates a path for the company to earn a premium multiple versus other Medicaid-heavy home care providers that remain stuck in a labor-arbitrage framework.

Key Decisions for Investors

• Long ADUS on a 3-6 month horizon; use pullbacks tied to Illinois payment timing or Texas legislative uncertainty as entries. Risk/reward is favorable if margin stays >12% and same-store personal care hours hold above 2%, because the stock can re-rate on durable FCF conversion rather than just revenue growth.
• Add to ADUS versus a basket of higher-leverage healthcare services names on a relative-value basis. The cleaner balance sheet and acquisition optionality make ADUS better insulated if Medicaid policy headlines turn noisy over the next 1-2 quarters.
• Buy ADUS call spreads into the Texas rate decision window (30-60 days). Structure for upside if a rate increase lands, while capping premium outlay in case the state delays or disappoints.
• If owned, use strength to hedge with a partial short in a home-health-heavy peer basket over the next 1-2 quarters. ADUS appears better positioned than smaller operators that lack density, labor tools, and balance-sheet flexibility.
• Set a tactical stop on the long if Illinois DSO deteriorates further without corresponding cash receipts by next quarter-end. That would signal collections risk rather than just timing noise and could compress the multiple quickly.